In a surprising move, the U.S. Food and Drug Administration (FDA) has opted not to approve a needle-free alternative to the EpiPen for emergency treatment of severe allergic reactions.
Sep 21, 2023
0
28
Amid record-high temperatures globally, a study Monday reveals that a few days of searing heat can be enough to prevent billions of people already living hand-to-mouth on daily wages from putting food on the table.
Aug 21, 2023
0
38
Americans ages 60 and up can get their vaccine for respiratory syncytial virus (RSV) this fall, the U.S. Centers for Disease Control and Prevention has announced.
Jul 3, 2023
0
47
An advisory panel to the U.S. Food and Drug Administration voted unanimously on Thursday to recommend that COVID-19 booster shots be updated for the fall to protect solely against one of the three XBB variants that have taken ...
Jun 16, 2023
0
2
In a position statement issued by the North American Menopause Society and published online June 1 in Menopause, updated recommendations are presented for the nonhormonal management of menopause-associated vasomotor symptoms.
Jun 12, 2023
0
2
A U.S. Food and Drug Administration advisory panel on Thursday recommended that the agency approve an RSV vaccine for infants and some toddlers.
Jun 9, 2023
0
2
A presidential panel of the American Psychological Association has issued recommendations for the use of social media by adolescents, noting that while these platforms can promote healthy socialization, their use should be ...
May 9, 2023
0
3
Paxlovid, a medication that has helped millions of high-risk COVID-19 patients avoid hospitalization and death since late 2021, moved one step closer to getting full approval from the U.S. Food and Drug Administration on ...
Mar 20, 2023
0
5
A United States Food and Drug Administration mandate to limit the dosage of acetaminophen in pills that combine acetaminophen and opioid medications is significantly associated with subsequent reductions in serious liver ...
Mar 7, 2023
0
18
The U.S. Food and Drug Administration's key science advisory panel, the Vaccines and Related Biological Products Advisory Committee, met on Jan. 26, 2023, to chart a path forward for COVID-19 vaccine policy. During the all-day ...
Jan 30, 2023
0
13
